
Pharmaceuticals in Asia-Pacific
Description
Pharmaceuticals in Asia-Pacific
Summary
Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
- The Asia-Pacific pharmaceuticals market registered revenues of $391.3 billion in 2023, representing a compound annual growth rate (CAGR) of 6.5% between 2018 and 2023.
- China dominated the Asia-Pacific pharmaceuticals market in 2023, accounting for the largest share of 41.1% in 2023.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Asia-Pacific
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Asia-Pacific
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific pharmaceuticals market with five year forecasts
- What was the size of the Asia-Pacific pharmaceuticals market by value in 2023?
- What will be the size of the Asia-Pacific pharmaceuticals market in 2028?
- What factors are affecting the strength of competition in the Asia-Pacific pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Asia-Pacific's pharmaceuticals market?
Table of Contents
43 Pages
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Geography segmentation
- 1.4. Market rivalry
- 1.5. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What strategies do leading players follow?
- 7.3. What are the recent developments in the market?
- 8 Company Profiles
- 8.1. CSPC Pharmaceutical Group Ltd
- 8.2. Takeda Pharmaceutical Co Ltd
- 8.3. Shanghai Pharmaceuticals Holding Co Ltd
- 8.4. Sinopharm Group Co Ltd
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Asia-Pacific pharmaceuticals market value: $ billion, 2018-23
- Table 2: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2023
- Table 3: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2023-28
- Table 4: CSPC Pharmaceutical Group Ltd: Key Facts
- Table 5: CSPC Pharmaceutical Group Ltd: Annual Financial Ratios
- Table 6: CSPC Pharmaceutical Group Ltd: Key Employees
- Table 7: Takeda Pharmaceutical Co Ltd: Key Facts
- Table 8: Takeda Pharmaceutical Co Ltd: Annual Financial Ratios
- Table 9: Takeda Pharmaceutical Co Ltd: Key Employees
- Table 10: Takeda Pharmaceutical Co Ltd: Key Employees Continued
- Table 11: Shanghai Pharmaceuticals Holding Co Ltd: Key Facts
- Table 12: Shanghai Pharmaceuticals Holding Co Ltd: Annual Financial Ratios
- Table 13: Shanghai Pharmaceuticals Holding Co Ltd: Key Employees
- Table 14: Sinopharm Group Co Ltd: Key Facts
- Table 15: Sinopharm Group Co Ltd: Annual Financial Ratios
- Table 16: Sinopharm Group Co Ltd: Key Employees
- Table 17: Asia-Pacific Exchange Rate, 2018-23
- List of Figures
- Figure 1: 220 Laboratories Inc: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Figure 2: 220 Laboratories Inc: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024)
- Figure 3: 220 Laboratories Inc: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.